The global demand for Microfluidic Devices Market is presumed to reach the market size of nearly USD 98.91 MN by 2028 from USD 22.7 MN in 2021 with a CAGR of 23.4% under the study period 2022 - 2028.
Microfluidics studies and analyzes the behavior of fluids flowing via technologically sophisticated microminiaturized devices comprising of tunnels and chambers. Microfluidic devices are manufactured from MEMS (Micro-Electro-Mechanical Systems) devices and can play a role in various healthcare applications, like point-of-care diagnostics, drug delivery, and clinical diagnostics. Microfluidic devices have several other applications in the field of cell biology and protein crystallization. Microfluidic devices offer other advantages for genomics which include reduced reagent consumption, improved test speed, and efficacy.
The microfluidic devices market is expected to showcase a healthy growth rate during the forecast period. The microfluidic devices market is experiencing vast growth globally owing to the raising research and development investment in life science, pharmaceuticals, and increasing point-of-care testing demand. The application of cost-effective materials for the manufacturing of microfluidic devices is likely to boost the microfluidic devices market growth globally. Furthermore, the rising usage of microfluidic chips for biomedical applications is also driving the microfluidic devices market growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of microfluidic devices. The growth and trends of microfluidic devices industry provide a holistic approach to this study.
This section of the microfluidic devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
- In-Vitro Diagnostics
- Medical Devices
- Point Of Care Testing
- Pharmaceutical And Life Science Research
- Drug Delivery
- Analytical Devices
- Clinical And Veterinary Diagnostics
- Environment And Industrial
This section covers the regional outlook, which accentuates current and future demand for the Microfluidic Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Microfluidic Devices Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the microfluidic devices market include Roche Diagnostics., Abbott Laboratories., Siemens Healthcare., Agilent Technologies., Bio-Rad Laboratories Inc., Fluidigm Corporation., Johnson & Johnson. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.